Short answer: A prescriber’s checklist for compounding referrals covers four areas: the prescription itself (named patient, active, strength, dosage form), the formulation brief (excipient exclusions, vehicle preferences, clinical rationale), GCP compliance (confirming the pharmacy operates under Good Compounding Practice on a prescription-only basis), and the review plan (follow-up timing, reassessment triggers). Every compounded preparation is made for one named patient on a doctor’s prescription — this checklist ensures the referral is complete and the pharmacy can prepare the formulation without delay.A Using a structured checklist reduces back-and-forth queries, shortens time to preparation, and helps the pharmacy deliver a formulation that matches the prescriber’s clinical intent.
Why a checklist matters in compounding referrals
Compounding referrals differ from standard prescribing because the pharmacy needs both a legal prescription and a practical formulation brief to prepare the product. When information is missing, the pharmacy must contact the clinic for clarification, which delays preparation. A checklist ensures that every referral includes the minimum information the pharmacy needs to assess feasibility, confirm compatibility and stability, and prepare the formulation to specification.
The checklist is not a substitute for clinical judgement — it is a structural tool that helps the prescriber communicate the clinical intent clearly. The four items below cover the information the pharmacy needs in almost every referral, regardless of the active ingredient or dosage form.
Checklist item 1: The prescription
Every compounded preparation requires a prescription from a registered doctor. The prescription should include:
- Patient name (named-patient compounding)
- Active ingredient and strength
- Requested dosage form (capsule, liquid, cream, tonic or serum)
- Prescriber’s signature and date
No compounded preparation is made without a valid prescription. This is the regulatory and clinical basis for the preparation.A
The most common omission on compounding prescriptions is the dosage form. A prescription that names the active and strength but does not state whether a capsule, liquid or cream is needed leaves the pharmacy to guess. If the prescriber is uncertain, this should be flagged as a question for the pharmacy rather than left blank — the pharmacy can advise on which form is most practical for the requested active.
Checklist item 2: The formulation brief
Beyond the prescription, a concise formulation brief helps the pharmacy assess practicality and prepare the formulation to specification. Include:
- Clinical rationale for compounding
- Anatomical site (for topical preparations)
- Known excipient exclusions or sensitivities
- Previous product tolerability issues
- Vehicle or delivery form preferences (e.g. liposomal where appropriate)
The pharmacy may advise on compatibility or stability before finalising. Treat this as a collaborative discussion.B
The formulation brief does not need to be lengthy. A few sentences covering why compounding is being considered, what has been tried before, and what the prescriber wants to achieve is usually sufficient. The key is to give the pharmacy enough context to assess whether the requested formulation is practical and to flag any issues before preparation begins.
Checklist item 3: GCP compliance
Confirm that the compounding pharmacy operates under Good Compounding Practice (GCP) on a prescription-only, named-patient basis. This is the quality framework that distinguishes patient-specific compounding from over-the-counter supplement sales or contract manufacturing. A pharmacy that cannot confirm GCP operation, or that positions itself as an OEM or white-label producer, is not operating in the model that serves clinical referrals.AC
For prescribers referring for the first time, it is reasonable to ask the pharmacy to confirm its compounding standard before sending a prescription. This is not an administrative hurdle — it is a quality check that ensures the preparation is made under a recognised compounding framework rather than as a generic supplement product.
Checklist item 4: The review plan
Set the review plan before the patient begins the preparation. Include:
- When to assess response
- What signs should trigger reassessment or return to clinic
- Duration of use and repeat supply expectations
- How the beyond-use date fits into the review timeline
The preparation carries a beyond-use date — not a factory expiry — so the review plan should align with the preparation’s stability window.D
If repeat supply is likely, the prescriber should note this in the referral so the pharmacy can advise on batch size and stability. The review plan also helps the patient understand when to return for follow-up and what to watch for between visits.
Common gaps in compounding referrals
Even experienced prescribers can miss items on the checklist when referrals are rushed. The most common gaps include:
- Omitting the dosage form from the prescription
- Not noting excipient sensitivities that could affect formulation choice
- Leaving the review plan vague or unstated
- Not confirming the pharmacy’s compounding standard before the first referral
Each of these gaps can delay preparation or result in a formulation that does not fully match the prescriber’s intent. A brief review of the four checklist items before sending the referral usually prevents these issues.
How this fits the Lynnity practice context
Lynnity Pharma is a non-sterile compounding pharmacy based in Kuala Lumpur, serving the Klang Valley with practitioner referrals and enquiries also coming from Singapore. The service operates on a prescription-only, named-patient basis under Good Compounding Practice, covering capsules, liquids, creams, tonics and serums.AC For prescribers referring to Lynnity, the four-item checklist above covers the information the pharmacy needs to assess and prepare a formulation. Prescribers can contact the pharmacy to discuss formulation feasibility before finalising the prescription.
Frequently asked questions
What must a prescriber include on a compounding prescription?
The prescription must name the patient, specify the active ingredient and strength, state the requested dosage form, and carry the prescriber’s signature and date. No compounded preparation is made without a valid, named-patient prescription.A
What is a formulation brief and why does the pharmacy need one?
A formulation brief adds clinical context — the rationale, anatomical site, excipient exclusions, vehicle preferences and review plan. It helps the pharmacy assess whether the requested formulation is practical and prepare it to specification. It is a collaborative step, not an administrative one.B
How does a prescriber confirm GCP compliance?
Confirm that the pharmacy operates under Good Compounding Practice on a prescription-only, named-patient basis. A pharmacy that positions itself as an OEM, white-label producer or that does not require a prescription is not operating under the GCP compounding model.A
What happens if the dosage form is not specified on the prescription?
The pharmacy will need to contact the prescriber to confirm whether a capsule, liquid, cream, tonic or serum is needed. This delays preparation. If the prescriber is unsure which form is most appropriate, the pharmacy can advise before the prescription is finalised.
How does the beyond-use date affect the review plan?
Compounded preparations carry a beyond-use date rather than a factory expiry date. The review plan should align with this stability window so the prescriber knows when to assess response and whether repeat supply is needed before the preparation’s beyond-use date expires.D
Reviewed by Vitthia Rama Murti, RPh (RPh 15632)
For practitioner enquiries, clinicians can discuss referral requirements and patient-specific formulation needs with the Lynnity team.
Grounding source A: Lynnity Pharma blog post ID 374663, https://www.lynnitypharma.com/blog/compounded-pregnenolone-malaysia/
Grounding source B: Lynnity Pharma blog post ID 374640, https://www.lynnitypharma.com/blog/compounded-citicoline-cdp-choline-malaysia/
Grounding source C: Lynnity Pharma blog post ID 374329, https://www.lynnitypharma.com/blog/personalised-vitamin-d-compounding-malaysia/
Grounding source D: Lynnity Pharma blog post ID 374505, https://www.lynnitypharma.com/blog/beyond-use-dating-compounded-supplements-malaysia/